Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Baglin, A."'
Publikováno v:
Blood. 140:460-461
Autor:
Ty E. Adams, Stéphanie G. I. Polderdijk, Trevor Baglin, Rodney M. Camire, Lacramioara Ivanciu, James A. Huntington
Publikováno v:
Blood. 129:105-113
Hemophilia is a bleeding disorder caused by deficiency in factors VIII or IX, the two components of the intrinsic Xase complex. Treatment with replacement factor can lead to the development of inhibitory antibodies, requiring the use of bypassing age
Publikováno v:
Blood. 91:1140-1144
A new factor V mutation associated with resistance to activated protein C and thrombosis (factor V Cambridge, Arg306→Thr) was found in one patient from a carefully selected group of 17 patients with venous thrombosis and confirmed APC resistance in
Autor:
Nadine Martin-Garcia, Philippe Gaulard, Karim Belhadj, Nicolas Mounier, Stéphane Cheze, Jean Alain Kummer, Felix Reyes, Vincent Ribrag, Françoise Berger, Céline Bossard, Josette Brière, Anne-Catherine Baglin, Jacques Bosq, Christian Gisselbrecht
Publikováno v:
Blood. 109:2183-2189
Nasal NK/T-cell lymphoma is a rare disease entity with a poor outcome. Expression of antiapoptotic proteins has not been extensively investigated in this entity. Forty-eight patients with nasal T/NK-cell lymphoma who received first-line polychemother
Autor:
Ri Liesner, Charles R. M. Hay, Simon A. Brown, Trevor Baglin, John Hanley, Michael Makris, Gerard Dolan, Sybil Hirsch, Peter William Collins, David Keeling
Publikováno v:
Blood. 109:1870-1877
Acquired hemophilia A is a severe bleeding disorder caused by an autoantibody to factor VIII. Previous reports have focused on referral center patients and it is unclear whether these findings are generally applicable. To improve understanding of the
Publikováno v:
Blood. 96:1816-1819
Cytochrome P-450 2C9 is the principle enzyme that terminates the anticoagulant effect of warfarin. Genetic polymorphisms inCYP2C9 producing variants with altered catalytic properties have been identified. Patients (n = 561) with a target internationa
Publikováno v:
Blood. 91:508-515
The importance of lipoproteins in the etiology of atherosclerosis is well established. Evidence is now accumulating to implicate thrombin in the pathogenesis of atherosclerosis. We have investigated whether atherogenic lipoproteins can support thromb
Autor:
Rupert Bauersachs, Dialina Brilhante, G T Gerotzafias, Mario Mandalà, Simon Noble, Henri Bounameaux, Ramón Lecumberri, Anna Falanga, H. R. Büller, Michael B. Streiff, C. Baglin, Nissim Haim, Manuel Monreal, Alok A. Khorana, Michel Marty, Dominique Farge, Mohammed H. Qari, Shaker A. Mousa, Philippe Debourdeau, M Beckers, Ingrid Pabinger, Barry M. Brenner, Paolo Prandoni, Ajay K. Kakkar, Martin H. Prins, Konstantinos N. Syrigos
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(1), 71-80. Wiley
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Abstract 4357 Background Use of long term indwelling central venous catheter (CVC) is associated with symptomatic (Σ) events in up to 30% of cancer patients (pts), which may lead to pulmonary embolism (PE) and loss of the CVC. Lack of consensus on m
Autor:
Debourdeau Philippe, Nissim Haim, Shaker S Mousa, Michel Marthy, C. Baglin, Beckers Marielle, Konstantin Syrigos, Martin H. Prins, Harry R. Büller, Mohammed H. Qari, Mario Mandalà, Ajay K. Kakkar, Manuel Monreal, Paolo Prandoni, Benjamin Brenner, Grigoris T. Gerotziafas, Ingrid Pabinger, Farge Dominique, Simon Noble, Michael B. Streiff, Anna Falanga, Alok A. Khorana, Ramón Lecumberri, Henri Bounameaux, Dialina Brilhante, Rupert Bauersachs
Publikováno v:
Blood. 120:1161-1161
Abstract 1161 Background Heterogeneity in clinical practices worldwide for Venous Thromboembolism (VTE) is a major challengs. This concern led us to establish international good clinical practices guidelines (GCPG) for the management VTE in cancer pa
Autor:
Alberto Tosetto, Gualtiero Palareti, Daniela Poli, Maura Marcucci, Sabine Eichinger, Mary Cushman, Alfonso Iorio, Campbell Tait, Trevor Baglin, James D. Douketis
Publikováno v:
Blood. 118:544-544
Abstract 544 Background. In patients with unprovoked venous thromboembolism (VTE) occurring in the absence of major provoking factors, the optimal duration of anticoagulation is anchored on estimating the risk for disease recurrence in the individual